“CONSEQUENCES OBSERVED WHEN MEROPENEM IS ADMINISTERED TO PATIENTS WITH COVID-19”. E Conference Zone, Mar. 2024, pp. 34-35, https://econferencezone.org/index.php/ecz/article/view/2743.